Stock · TORNTPHARM · Pharmaceuticals
TORNTPHARM share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for Torrent Pharmaceuticals Limited, refreshed every end-of-day run. A systematic, data-only read on Torrent Pharmaceuticals Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum. Refreshed from real price structure each run.
The verdict
BazaarBaazi reads TORNTPHARM as constructive with a Crack Score of 98/100 as of 9 Jun 2026.
BazaarBaaziSource & method
Price target: support and resistanceComputed 9 Jun 2026
Support and resistance for TORNTPHARM are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 9 Jun 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the TORNTPHARM chart, refreshed every end-of-day run.
The Crack Score, and how it is built98 / 100 · High conviction
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for TORNTPHARM, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on TORNTPHARM reads right now.
The futures and options read on TORNTPHARM leans to a call-side build. Strike-level positioning is read inside the latest show, against the printed spot. Single-stock F&O on TORNTPHARM is thinner than the index, so open-interest shifts read with more noise; the desk weights price structure over raw OI. This is a structural reading of positioning, not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving TORNTPHARM.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 9 Jun 2026. Why TORNTPHARM moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
Torrent Pharmaceuticals Limited's most recent quarter, parsed straight from the official NSE filing. Every figure links back to its primary source.
Result Pulse
40 / 100Revenue
Rs 4,197 crNet profit
Rs 364 crEPS (quarter)
Rs 11.51| Growth | YoY | QoQ |
|---|---|---|
| Revenue | +41.8% | +27.1% |
| Net profit | -26.9% | -42.7% |
| Net margin | +8.7% | |
Figures are the Q4 FY26 result for TORRENT PHARMACEUTICALS LIMITED, parsed straight from the official NSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the TORNTPHARM chart. Not a substitute for a registered research note.
| Ticker | TORNTPHARM |
|---|---|
| Full name | Torrent Pharmaceuticals Limited |
| Sector | Pharmaceuticals |
| Index class | LARGE CAP |
| ISIN | NSE-TORNTPHARM |
| Market-cap band | ~1.5 lakh cr |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 9 Jun 2026 |
| Aliases tracked | TORNTPHARM |
Reference chart4 Sep 2025
The daily frame the desk reads on TORNTPHARM.
FAQ8 reader questions · AEO-eligible
The line on TORNTPHARM, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the TORNTPHARM share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on TORNTPHARM. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 9 Jun 2026.
What is BazaarBaazi's Crack Score for TORNTPHARM?
The BazaarBaazi Crack Score for TORNTPHARM is 98 out of 100 as of 9 Jun 2026, a high conviction reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on TORNTPHARM?
As of 9 Jun 2026, BazaarBaazi reads TORNTPHARM positioning as a call-side build. This is a structural reading of the option chain, not a derivatives recommendation.
What sector is TORNTPHARM in and which peers does BazaarBaazi track?
TORNTPHARM sits in Pharmaceuticals (large cap), indicative market cap ~1.5 lakh cr, ISIN NSE-TORNTPHARM. The peers BazaarBaazi reads alongside it are Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited. A systematic, data-only read on Torrent Pharmaceuticals Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum. Refreshed from real price structure each run.
How often is the TORNTPHARM view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on TORNTPHARM is bullish, published in Systematic Read on 9 Jun 2026.
What was TORRENT PHARMACEUTICALS LIMITED's Q4 FY26 net profit?
TORRENT PHARMACEUTICALS LIMITED reported a net profit of Rs 364 cr for Q4 FY26 (the quarter ended 31 March 2026). That is -26.9% year on year. The figure is from the company's official NSE filing.
What was TORRENT PHARMACEUTICALS LIMITED's Q4 FY26 revenue?
TORRENT PHARMACEUTICALS LIMITED reported revenue of Rs 4,197 cr for Q4 FY26. That is +41.8% year on year. The figure is from the company's official NSE filing.
How does BazaarBaazi rate TORRENT PHARMACEUTICALS LIMITED's Q4 FY26 result?
BazaarBaazi gives TORRENT PHARMACEUTICALS LIMITED's Q4 FY26 result a Result Pulse of 40 out of 100, with a verdict of Mixed. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
Related stock views
The names BazaarBaazi reads alongside TORNTPHARM, each a living view refreshed every end-of-day run.
Hub
All stock views
The full BazaarBaazi coverage universe, scored and dated.
Pharmaceuticals
SUNPHARMA
Sun Pharmaceutical Industries Limited
Pharmaceuticals
DRREDDY
Dr. Reddy's Laboratories Limited
Pharmaceuticals
CIPLA
Cipla Limited
Pharma APIs and CDMO
DIVISLAB
Divi's Laboratories Limited
Pharmaceuticals
ZYDUSLIFE
Zydus Lifesciences Limited